Oesophageal carcinoma - The Lancet
Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
Frontiers | “Targeted” Chemotherapy for Esophageal Cancer
Oesophageal cancer incidence statistics | Cancer Research UK
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma | NEJM
Advances in targeted therapy for esophageal cancer | Signal Transduction and Targeted Therapy
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial - The Lancet Oncology
Oesophageal cancer risk | Cancer Research UK
SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus | BMC Cancer | Full Text
Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
Cell-free DNA analysis in current cancer clinical trials: a review | British Journal of Cancer
Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends | Nature Reviews Gastroenterology & Hepatology
Cancers | Free Full-Text | The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
Men's oesophageal cancer risk "triple that of women" - PMLiVE
Advances in the curative management of oesophageal cancer | British Journal of Cancer
New option to treat advanced oesophageal cancer approved for NHS in Scotland - Cancer Research UK - Cancer news
Stage 0 (high grade dysplasia) | Oesophageal cancer | Cancer Research UK
A trial looking at improving chemoradiotherapy for people with cancer of the food pipe (SCOPE 2) | Cancer Research UK
Oesophageal cancer risk | Cancer Research UK
UK NICE recommends BMS' nivolumab for oesophageal cancer
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
A trial of additional treatment for oesophageal cancer and stomach cancer (PLATFORM) | Cancer Research UK
Pembrolizumab Approved for Esophageal Cancer - NCI
A trial looking at improving chemoradiotherapy for people with cancer of the food pipe (SCOPE 2) | Cancer Research UK
